The Proof of Concept Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Mild and Moderate COVID-19
Clinical trial NCT04891302 · COMPLETED
Trial details
- NCT number
- NCT04891302
- Sponsor
- Bukwang Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-19
- Primary completion
- 2021-07-05
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.